Abstract
Objective To evaluate the preference and satisfaction in the Chinese Parkinson’s disease (PD) patients treated with deep brain stimulation (DBS).
Background DBS is a widely used therapy for PD. There is now a choice between fixed-life implantable pulse generators (IPGs) and rechargeable IPGs, each having their advantages and disadvantages.
Methods Two hundred and twenty PD patients treated with DBS completed a self-designed questionnaire to assess long-term satisfaction and experience with the type of battery they had chosen, and the key factors affecting their choices. The survey was performed online and double-checked for completeness and accuracy.
Results The median value of follow-up length was 18 months. 87.3% of the DBS used rechargeable IPGs (r-IPG). The choice between rechargeable and non-rechargeable IPGs was significantly associated with the patient’s affordability (
, p < 0.001). Interestingly, the feature of remote programming significantly affected patients’ choices between domestic and imported brands (
, p < 0.001). 87.7% of the patients were satisfied with the stimulating effects as well as the implanted device. 40.6% of the patients with r-IPGs felt confident handling their devices within one week after discharge. More than half of the patients checked their batteries every week. The mean interval for battery recharge was 4.3 days. 57.8% of the patients spent around one-hour recharging and 71.4% of them recharged the battery independently. The most popular way for patients to learn about DBS surgery was through media (79/220, 35.9%), including the Internet and television programs. The rehabilitation (40.6%, 78/192), and programming (36.5%, 70/192) were two main courses that most patients wanted to learn after surgery.
Conclusion Most patients were satisfied with their choices of IPGs. The patients’ financial status and remote programming function were the two most critical factors in their decision. The skill of using rechargeable IPG was easy to master by most patients.
Competing Interest Statement
This study was supported by the 2018 Shanghai Municipal Education Commission—Gaoyuan Nursing Grant Support (Hlgy1804kyx).
Funding Statement
This study was supported by the 2018 Shanghai Municipal Education Commission—Gaoyuan Nursing Grant Support (Hlgy1804kyx).
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data included in this manuscript is all collected from patients in our center, none data from other other dataset is used in our manuscript.
